{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:07:55Z","timestamp":1778627275912,"version":"3.51.4"},"reference-count":246,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1132975"],"award-info":[{"award-number":["1132975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1132975"],"award-info":[{"award-number":["APP1132975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.tube.2023.102307","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T10:59:14Z","timestamp":1673693954000},"page":"102307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant"],"prefix":"10.1016","volume":"139","author":[{"given":"Viet Tram","family":"Duong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-807X","authenticated-orcid":false,"given":"Mariusz","family":"Skwarczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2023.102307_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.smim.2018.07.001","article-title":"Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination","volume":"39","author":"Coppola","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","article-title":"Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence","volume":"16","author":"Smith","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2023.102307_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG \u2014 implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2023.102307_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molmed.2012.07.008","article-title":"Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions","volume":"18","author":"Gowthaman","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.tube.2023.102307_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tube.2012.11.011","article-title":"The dual face of central nervous system tuberculosis: a new Janus Bifrons?","volume":"93","author":"S\u00e1enz","year":"2013","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2023.102307_bib7","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1016\/j.celrep.2019.11.103","article-title":"Bystander activation of pulmonary trm cells attenuates the severity of bacterial pneumonia by enhancing neutrophil recruitment","volume":"29","author":"Ge","year":"2019","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.tube.2023.102307_bib8","first-page":"11","article-title":"On the mechanics of droplet nuclei infection; quantitative experimental air-borne tuberculosis in rabbits","volume":"47","author":"Wells","year":"1948","journal-title":"Am J Hyg"},{"key":"10.1016\/j.tube.2023.102307_bib9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.cell.2014.11.024","article-title":"Host evasion and exploitation schemes of Mycobacterium tuberculosis","volume":"159","author":"Cambier","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tube.2023.102307_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri3259","article-title":"The immunological life cycle of tuberculosis","volume":"12","author":"Ernst","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/IAI.67.1.74-79.1999","article-title":"Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro","volume":"67","author":"Manca","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.142.1.1","article-title":"Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival","volume":"142","author":"Armstrong","year":"1975","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2023.102307_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/mi.2011.3","article-title":"Apoptosis is an innate defense function of macrophages against","volume":"4","author":"Behar","year":"2011","journal-title":"Mycobacterium tuberculosis. Mucosal Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10875-007-9084-0","article-title":"Host innate immune response to Mycobacterium tuberculosis","volume":"27","author":"Bhatt","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2023.102307_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/path.1906","article-title":"New insights into the function of granulomas in human tuberculosis","volume":"208","author":"Ulrichs","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.tube.2023.102307_bib17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/iai.63.4.1491-1497.1995","article-title":"Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis","volume":"63","author":"Boesen","year":"1995","journal-title":"Infect Immun"},{"issue":"Suppl 2","key":"10.1016\/j.tube.2023.102307_bib20","doi-asserted-by":"crossref","first-page":"ii54","DOI":"10.1136\/ard.61.suppl_2.ii54","article-title":"Protection against tuberculosis: cytokines, T cells, and macrophages","volume":"61","author":"Kaufmann","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.tube.2023.102307_bib21","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1128\/IAI.68.6.3269-3274.2000","article-title":"Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis","volume":"68","author":"Silva","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib22","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.coi.2014.02.003","article-title":"Novel vaccine approaches for protection against intracellular pathogens","volume":"28","author":"Griffiths","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2023.102307_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis","volume":"5","author":"Prezzemolo","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib26","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-\u03b3 \u2013receptor deficiency in an infant with fatal bacille calmette\u2013gu\u00e9rin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2023.102307_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/14656566.5.3.581","article-title":"The use of TNF-\u03b1 blocking agents in rheumatoid arthritis: an overview","volume":"5","author":"Toussirot","year":"2004","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.tube.2023.102307_bib28","first-page":"185","article-title":"Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy","volume":"1","author":"J","year":"1995","journal-title":"Cytokines Mol Ther"},{"key":"10.1016\/j.tube.2023.102307_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.immunol.021908.132723","article-title":"Regulatory T cells in the control of host-microorganism interactions","volume":"27","author":"Belkaid","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Federica","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.tube.2023.102307_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","article-title":"CD8 T cells and Mycobacterium tuberculosis infection","volume":"37","author":"Lin","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.tube.2023.102307_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"Orme","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2023.102307_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2015.11.012","article-title":"Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates","volume":"102","author":"Agger","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tube.2023.102307_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni.1718","article-title":"Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus","volume":"10","author":"Thomas","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib35","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/eji.200940279","article-title":"A key role for lung\u2010resident memory lymphocytes in protective immune responses after BCG vaccination","volume":"40","author":"Connor","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tube.2017.02.003","article-title":"Variable BCG efficacy in rhesus populations: pulmonary BCG provides protection where standard intra-dermal vaccination fails","volume":"104","author":"Verreck","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2023.102307_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.tube.2023.102307_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/CVI.00289-15","article-title":"Evaluation of the immunogenicity of Mycobacterium bovis BCG delivered by aerosol to the lungs of macaques","volume":"22","author":"White","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib39","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41385-018-0065-9","article-title":"Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis","volume":"11","author":"Fl\u00f3rido","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135009","article-title":"AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates: e0135009","volume":"10","author":"Jeyanathan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2023.102307_bib42","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1016\/j.celrep.2017.03.007","article-title":"Th1 differentiation drives the accumulation of intravascular, non-protective CD4 T cells during tuberculosis","volume":"18","author":"Sallin","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.tube.2023.102307_bib43","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Hans-Willi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2023.102307_bib44","first-page":"1073","volume":"182","author":"Kagina","year":"2010","journal-title":"Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Gu\u00e9rin Vaccination of Newborns"},{"key":"10.1016\/j.tube.2023.102307_bib45","series-title":"Deciphering protective immunity against tuberculosis: implications for vaccine development","first-page":"353","author":"Counoupas","year":"2019"},{"key":"10.1016\/j.tube.2023.102307_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01262","article-title":"Polyfunctional CD4(+) T cells as targets for tuberculosis vaccination","volume":"8","author":"Lewinsohn","year":"2017","journal-title":"Front Immunol"},{"issue":"369","key":"10.1016\/j.tube.2023.102307_bib47","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib48","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1128\/IAI.01392-09","article-title":"Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon","volume":"78","author":"Wozniak","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib49","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib50","article-title":"PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection","volume":"13","author":"Anneliese","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib51","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.20100265","article-title":"Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis","volume":"207","author":"Cruz","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2023.102307_bib52","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.160.5.2374","article-title":"Human purified protein derivative-specific CD4 super(+) T cells use both CD95-dependent and CD95-independent cytolytic mechanisms","volume":"160","author":"Lewinsohn","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib53","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.167.5.2734","article-title":"CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas\/Fas ligand-independent mechanism","volume":"167","author":"Canaday","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib54","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1164\/rccm.200306-837OC","article-title":"Mycobacterium tuberculosis-specific CD8\u02c6sup +\u02c6 T cells preferentially recognize heavily infected cells","volume":"168","author":"Lewinsohn","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2023.102307_bib55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jlb.66.5.763","article-title":"Macrophage apoptosis in mycobacterial infections","volume":"66","author":"Fratazzi","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.tube.2023.102307_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tube.2023.102307_bib57","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"Von Reyn","year":"2010","journal-title":"Aids"},{"key":"10.1016\/j.tube.2023.102307_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis (role of CD8 T cells in anti-tuberculosis immunity)","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2023.102307_bib60","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/eji.201444954","article-title":"Epitope\u2010specific CD4+, but not CD8+, T\u2010cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection","volume":"45","author":"Fl\u00f3rido","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib61","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/eji.201344358","article-title":"High\u2010frequency vaccine\u2010induced CD8 + T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection","volume":"44","author":"Lindenstr\u00f8m","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib62","article-title":"Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages","author":"Yang","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.tube.2023.102307_bib63","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"Van Pinxteren","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib64","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/IAI.69.3.1722-1728.2001","article-title":"Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis","volume":"69","author":"Gonzalez-Juarrero","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib65","volume":"vol. 7","author":"Huang","year":"2016"},{"key":"10.1016\/j.tube.2023.102307_bib66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1462-5822.2005.00612.x","article-title":"Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension","volume":"8","author":"Tsai","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.tube.2023.102307_bib67","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajpath.2012.05.009","article-title":"Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis","volume":"181","author":"Phuah","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tube.2023.102307_bib68","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/rccm.201707-1475OC","article-title":"B cells producing type I IFN modulate macrophage polarization in tuberculosis","volume":"197","author":"B\u00e9nard","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2023.102307_bib69","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with <em>Mycobacterium tuberculosis<\/em&gt","volume":"178","author":"Maglione","year":"2007","journal-title":"J Immunol"},{"issue":"1301","key":"10.1016\/j.tube.2023.102307_bib70","article-title":"Effects of B Cell Depletion on Early <span class=\"named-content genus-species\" id=\"named-content-1\">Mycobacterium tuberculosis<\/span> Infection in Cynomolgus Macaques","volume":"84","author":"Phuah","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005687","article-title":"Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment","volume":"12","author":"Joosten","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2023.102307_bib72","first-page":"59","article-title":"Tuberculosis in children with congenital immunodeficiency syndromes","volume":"58","author":"Dogru","year":"2010","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.tube.2023.102307_bib73","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against <em>Mycobacterium tuberculosis<\/em&gt","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2023.102307_bib74","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.tube.2023.102307_bib75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2006.10.010","article-title":"Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity","volume":"122","author":"Sable","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib76","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/CVI.00718-14","article-title":"Tuberculosis vaccine types and timings","volume":"22","author":"Orme","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib77","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1471-4906(01)01865-8","article-title":"TB vaccines: progress and problems","volume":"22","author":"Andersen","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib78","first-page":"889","volume":"61","author":"Oyston","year":"2012","journal-title":"The curr challenges vaccine dev"},{"key":"10.1016\/j.tube.2023.102307_bib79","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib80","series-title":"Global tuberculosis report","author":"Organization","year":"2019"},{"key":"10.1016\/j.tube.2023.102307_bib81","first-page":"698","volume":"271","author":"Colditz","year":"1994","journal-title":"Effic BCG vac prevent tubercul: meta-anal publ literat"},{"key":"10.1016\/j.tube.2023.102307_bib82","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2023.102307_bib83","first-page":"S64","volume":"31","year":"2000","journal-title":"Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature"},{"key":"10.1016\/j.tube.2023.102307_bib84","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.101.3.313","article-title":"Antituberculous immunity induced in mice by vaccination with killed tubercle bacilli or with a soluble bacillary extract","volume":"101","author":"Weiss","year":"1955","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2023.102307_bib85","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/jb.94.5.1736-1745.1967","article-title":"Effects of oil-treated mycobacterial cell walls on the organs of mice","volume":"94","author":"Barclay","year":"1967","journal-title":"J Bacteriol"},{"key":"10.1016\/j.tube.2023.102307_bib86","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1183\/09031936.93.06060811","article-title":"Immunoprotective behavior of liposome-entrapped cell-wall subunit of mycobacterium-tuberculosis against experimental tuberculous infection in mice","volume":"6","author":"Chugh","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2023.102307_bib87","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/iai.56.12.3310-3312.1988","article-title":"Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines","volume":"56","author":"Orme","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib88","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/iai.60.11.4781-4792.1992","article-title":"Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a Guinea pig model of pulmonary tuberculosis","volume":"60","author":"Pal","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib89","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/iai.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib90","first-page":"502","article-title":"Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis","volume":"85","author":"Roberts","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2023.102307_bib91","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.tube.2023.102307_bib92","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/hiv.10.20","article-title":"Possible applications for replicating HIV-1 vectors","volume":"4","year":"2010","journal-title":"HIV Ther"},{"key":"10.1016\/j.tube.2023.102307_bib93","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"key":"10.1016\/j.tube.2023.102307_bib94","first-page":"3998","article-title":"immunity. Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of","volume":"67","author":"Skeiky","year":"1999","journal-title":"Mycobacter tubercul"},{"key":"10.1016\/j.tube.2023.102307_bib95","first-page":"2941","article-title":"Molecular characterization and human T-cell responses to a member of a novel","volume":"67","author":"Dillon","year":"1999","journal-title":"Mycobacterium tuberculosis mtb39 gene family"},{"key":"10.1016\/j.tube.2023.102307_bib96","volume":"7","author":"Billeskov","year":"2012","journal-title":"The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity"},{"key":"10.1016\/j.tube.2023.102307_bib97","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2023.102307_bib98","first-page":"7534","article-title":"Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding","volume":"98","author":"Sherman","year":"2001","journal-title":"\u03b1-crystallin"},{"key":"10.1016\/j.tube.2023.102307_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00969-16","article-title":"The enigmatic PE\/PPE multigene family of mycobacteria and tuberculosis vaccination","volume":"85","author":"Brennan","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib100","first-page":"7948","article-title":"Identification of human T cell antigens for the development of vaccines against","volume":"181","author":"Bertholet","year":"2008","journal-title":"Mycobacter tubercul"},{"key":"10.1016\/j.tube.2023.102307_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2023.102307_bib102","first-page":"307","article-title":"A family of cross-reacting proteins secreted by","volume":"36","author":"Wiker","year":"1992","journal-title":"Mycobacter tubercul"},{"key":"10.1016\/j.tube.2023.102307_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2023.102307_bib104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/a-1785-3936","article-title":"A new intranasal influenza vector-based vaccine TB\/FLU-04L against tuberculosis: preclinical safety studies","volume":"72","author":"Buzitskaya","year":"2022","journal-title":"Drug Res"},{"key":"10.1016\/j.tube.2023.102307_bib105","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.cellsig.2012.05.014","article-title":"Roles and underlying mechanisms of ESAT-6 in the context of Mycobacterium tuberculosis\u2013host interaction from a systems biology perspective","volume":"24","author":"Yu","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.tube.2023.102307_bib106","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pep.2007.11.016","article-title":"Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model","volume":"59","author":"Bai","year":"2008","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.tube.2023.102307_bib107","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molimm.2014.06.007","article-title":"A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice","volume":"62","author":"Li","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib108","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2023.102307_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002378","article-title":"Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner","volume":"7","author":"Chatterjee","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2023.102307_bib110","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1080\/07391102.2020.1844061","article-title":"Weak spots inhibition in the Mycobacterium tuberculosis antigen 85C target for antitubercular drug design through selective irreversible covalent inhibitor-SER124","volume":"40","author":"Adewumi","year":"2022","journal-title":"J Biomol Struct Dynam"},{"key":"10.1016\/j.tube.2023.102307_bib111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Karbalaei Zadeh Babaki","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tube.2023.102307_bib112","first-page":"6","article-title":"Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis","author":"Kumar","year":"2021","journal-title":"JCI insight"},{"key":"10.1016\/j.tube.2023.102307_bib113","volume":"10","author":"Qian","year":"2020","journal-title":"Role of the PE\/PPE Family in Host\u2013Pathogen Interactions and Prospects for Anti-Tuberculosis Vaccine and Diagnostic Tool Design"},{"key":"10.1016\/j.tube.2023.102307_bib114","first-page":"jcs228700","volume":"132","author":"Choi","year":"2019","journal-title":"PPE39 of the Mycobacterium tuberculosis strain Beijing\/K induces Th1-cell polarization through dendritic cell maturation"},{"key":"10.1016\/j.tube.2023.102307_bib115","first-page":"6269","volume":"183","author":"Nair","year":"2009","journal-title":"The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage"},{"key":"10.1016\/j.tube.2023.102307_bib116","first-page":"1907","article-title":"immunity","volume":"73","author":"Fink","year":"2005","journal-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells"},{"key":"10.1016\/j.tube.2023.102307_bib117","first-page":"2195","article-title":"Communications br. Vaccine potential of ESAT-6 protein fused with consensus CD4+ T-cell epitopes of PE\/PPE proteins against highly pathogenic","volume":"503","author":"Choi","year":"2018","journal-title":"Mycobacterium tuberculosis strain HN878"},{"key":"10.1016\/j.tube.2023.102307_bib118","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tube.2010.09.006","article-title":"The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomes","volume":"91","author":"Kapopoulou","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2023.102307_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153771","article-title":"A web-based platform for designing vaccines against existing and emerging strains of Mycobacterium tuberculosis","volume":"11","author":"Dhanda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11693-014-9135-9","article-title":"Integrative immunoinformatics for Mycobacterial diseases in R platform","volume":"8","author":"Chaudhuri","year":"2014","journal-title":"Syst synth biol"},{"key":"10.1016\/j.tube.2023.102307_bib121","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2174\/1389201018666170914150115","article-title":"PeMtb: a database of MHC antigenic peptide of Mycobacterium tuberculosis","volume":"18","author":"Zia","year":"2017","journal-title":"Curr Pharmaceut Biotechnol"},{"issue":"4","key":"10.1016\/j.tube.2023.102307_bib122","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.tube.2023.102307_bib123","series-title":"Developments in vaccine adjuvants","author":"Firdaus Fzs","year":"2022"},{"key":"10.1016\/j.tube.2023.102307_bib124","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1400478111","article-title":"Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants","volume":"111","author":"Maisonneuve","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2023.102307_bib125","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/cmi.12161","article-title":"Receptor-mediated recognition of mycobacterial pathogens","volume":"15","author":"Killick","year":"2013","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.tube.2023.102307_bib126","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.192.Supp.141.16","article-title":"Vaccination with a Hybrid 1 (H1) fusion protein combined with a liposomal adjuvant (CAF01) induced antigen specific T-cells 3 years post vaccination in a human clinical trial. (VAC7P.971)","volume":"192","author":"Henson","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053531","article-title":"The mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling","volume":"8","author":"Desel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib128","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1016\/j.vaccine.2013.07.022","article-title":"TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines","volume":"31","author":"Tyne","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib129","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/acs.bioconjchem.6b00116","article-title":"Potent antigen-adjuvant delivery system by conjugation of Mycobacterium tuberculosis Ag85B-HspX fusion protein with arabinogalactan-poly(I:C) conjugate","volume":"27","author":"Huang","year":"2016","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.tube.2023.102307_bib130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2023.102307_bib131","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.vaccine.2015.05.036","article-title":"The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: a randomized controlled trial","volume":"33","author":"Geldenhuys","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib132","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib133","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1038\/s41467-021-27029-6","article-title":"A Phase I\/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients","volume":"12","author":"Jenum","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2023.102307_bib134","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib135","first-page":"287","volume":"6","author":"Penn-Nicholson","year":"2018","journal-title":"Safety and immunogenicity of the novel tuberculosis vaccine ID93+ GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial"},{"key":"10.1016\/j.tube.2023.102307_bib136","article-title":"The role of syk\/CARD9-coupled C-type lectin receptors in immunity to infections","author":"Marakalala","year":"2010","journal-title":"Clinical and Developmental Immunology 2010"},{"key":"10.1016\/j.tube.2023.102307_bib137","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.sbi.2015.06.003","article-title":"Recent insights into structures and functions of C-type lectins in the immune system","volume":"34","author":"Drickamer","year":"2015","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.tube.2023.102307_bib138","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri2569","article-title":"Signalling through C-type lectin receptors: shaping immune responses","volume":"9","author":"Teunis","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib139","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.it.2016.10.009","article-title":"Recognition of mycobacterial lipids by immune receptors","volume":"38","author":"Ishikawa","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib140","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib141","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1084\/jem.20091750","article-title":"Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle","volume":"206","author":"Ishikawa","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2023.102307_bib142","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.72.3.1608-1617.2004","article-title":"Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines","volume":"72","author":"Holten-Andersen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib143","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20081445","article-title":"Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation","volume":"206","author":"Werninghaus","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2023.102307_bib144","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ijc.2910240614","article-title":"Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6\u2032-dimycolate) and synthetic analogues","volume":"24","author":"Pimm","year":"1979","journal-title":"Int J Cancer"},{"key":"10.1016\/j.tube.2023.102307_bib145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/iai.20.1.12-19.1978","article-title":"Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor)","volume":"20","author":"Parant","year":"1978","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib146","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"Lindenstr\u00f8m","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib147","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fimmu.2015.00430","article-title":"Characterization of the antigen-specific CD4(+) T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes","volume":"6","author":"Ciabattini","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib148","first-page":"494","volume":"143","author":"Hilgers","year":"1992","journal-title":"DDA as an immunol adj"},{"key":"10.1016\/j.tube.2023.102307_bib149","first-page":"4413","volume":"197","author":"Van Haren","year":"2016","journal-title":"Age-specific adjuvant synergy: dual TLR7\/8 and mincle activation of human newborn dendritic cells enables Th1 polarization"},{"key":"10.1016\/j.tube.2023.102307_bib150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib151","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/mi.2016.70","article-title":"Subunit vaccine H56\/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung","volume":"10","author":"Woodworth","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib152","series-title":"Advances in immunology","first-page":"1","article-title":"Toll-like receptors and innate immunity","author":"Akira","year":"2001"},{"key":"10.1016\/j.tube.2023.102307_bib153","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib154","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tube.2023.102307_bib155","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/1753425911426591","article-title":"Mycobacterium bovis bacilli Calmette-Guerin regulates leukocyte recruitment by modulating alveolar inflammatory responses","volume":"18","author":"Andersson","year":"2012","journal-title":"Innate Immun"},{"key":"10.1016\/j.tube.2023.102307_bib156","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.4049\/jimmunol.171.12.6820","article-title":"Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2","volume":"171","author":"Hertz","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib157","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/791392","article-title":"The role of airway epithelial cells in response to mycobacteria infection","volume":"2012","author":"Li","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib158","doi-asserted-by":"crossref","first-page":"ii17","DOI":"10.1136\/ard.62.suppl_2.ii17","article-title":"Roles of antimicrobial peptides such as defensins in innate and adaptive immunity","volume":"62","author":"Oppenheim","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.tube.2023.102307_bib159","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tube.2023.102307_bib160","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-\u03baB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.tube.2023.102307_bib161","first-page":"423","article-title":"The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection","volume":"84","author":"Cooper","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2023.102307_bib162","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.vaccine.2010.11.003","article-title":"Adjuvating the adjuvant: facilitated delivery of an immunomodulatory oligonucleotide to TLR9 by a cationic antimicrobial peptide in dendritic cells","volume":"29","author":"Aichinger","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib163","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1016\/j.vaccine.2006.03.071","article-title":"IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses","volume":"24","author":"Schellack","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib164","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.vaccine.2004.03.007","article-title":"The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a T H2-type immune response to co-injected antigens","volume":"22","author":"Fritz","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib165","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/eji.200737889","article-title":"Protective anti\u2010mycobacterial T cell responses through exquisite in vivo activation of vaccine\u2010targeted dendritic cells","volume":"38","author":"Kamath","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003683","article-title":"Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31\u00ae adjuvant (neonatal TB vaccine response)","volume":"3","author":"Kamath","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib167","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.vaccine.2006.03.072","article-title":"Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31","volume":"24","author":"Agger","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib168","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tube.2023.102307_bib169","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B\u2013ESAT-6 adjuvanted with IC31\u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib170","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B\u2013ESAT-6 adjuvanted with IC31 \u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in na\u00efve human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib171","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114602","article-title":"Safety and immunogenicity of H1\/IC31\u00ae, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells\/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial","volume":"9","author":"Reither","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib172","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/CVI.00092-15","article-title":"Antiviral innate immune activation in HIV-infected adults negatively affects H1\/IC31-induced vaccine-specific memory CD4+ T cells","volume":"22","author":"Lenz","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib173","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.1073\/pnas.1104588108","article-title":"Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells","volume":"108","author":"MacLeod","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2023.102307_bib174","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/CVI.00034-08","article-title":"Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone","volume":"15","author":"Wedlock","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib176","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.181.3.1849","article-title":"Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation","volume":"181","author":"Shen","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib177","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib178","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72\/AS01 in South African adults","volume":"188","author":"Day","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2023.102307_bib179","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tube.2016.07.005","article-title":"Safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomised study","volume":"100","author":"Gillard","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2023.102307_bib180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J Contr Release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.tube.2023.102307_bib181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib182","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.1102696","article-title":"The importance of adjuvant formulation in the development of a tuberculosis vaccine","volume":"188","author":"Baldwin","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib183","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.colsurfb.2009.08.022","article-title":"Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations","volume":"75","author":"Anderson","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.tube.2023.102307_bib184","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.vaccine.2009.03.018","article-title":"Intradermal immunization improves protective efficacy of a novel TB vaccine candidate","volume":"27","author":"Baldwin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib185","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/j.vaccine.2009.07.081","article-title":"Enhanced humoral and Type 1 cellular immune responses with Fluzone\u00ae adjuvanted with a synthetic TLR4 agonist formulated in an emulsion","volume":"27","author":"Baldwin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib186","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1128\/IAI.00508-09","article-title":"Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection","volume":"77","author":"Raman","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib187","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/eji.201141855","article-title":"A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T\u2010cell immunity in vivo","volume":"42","author":"Pantel","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib188","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1016\/j.vaccine.2011.07.094","article-title":"Protection of mice from Mycobacterium tuberculosis by ID87\/GLA-SE, a novel tuberculosis subunit vaccine candidate","volume":"29","author":"Windish","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib189","article-title":"Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-\u03b3","author":"Desbien","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2013.07.030","article-title":"Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis","volume":"172","author":"Orr","year":"2013","journal-title":"J Contr Release"},{"key":"10.1016\/j.tube.2023.102307_bib191","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jphp.12173","article-title":"Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants","volume":"66","author":"Hussain","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.tube.2023.102307_bib192","article-title":"Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE\/PPE proteins of","volume":"168","author":"Medha","year":"2022","journal-title":"Mycobacterium tuberculosis. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences"},{"key":"10.1016\/j.tube.2023.102307_bib193","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tube.2023.102307_bib194","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2012.09.004","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"64","author":"Anderson","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tube.2023.102307_bib195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/10611860801900462","article-title":"PLGA microspheres for the delivery of a novel subunit TB vaccine","volume":"16","author":"Kirby","year":"2008","journal-title":"J Drug Target"},{"key":"10.1016\/j.tube.2023.102307_bib196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2016.03.024","article-title":"Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: preparation and in vitro aerosol characterization","volume":"88","author":"Parumasivam","year":"2016","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.tube.2023.102307_bib197","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4161\/hv.6.12.13350","article-title":"A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB\/c mice against tuberculosis infection","volume":"6","author":"dos Santos","year":"2010","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib198","first-page":"350","article-title":"PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B","volume":"27","author":"Shi","year":"2010","journal-title":"An Off J Am Assoc Pharm Sci"},{"key":"10.1016\/j.tube.2023.102307_bib199","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.micpath.2018.10.023","article-title":"A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity","volume":"125","author":"Khademi","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tube.2023.102307_bib200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2017.12.003","article-title":"A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522","volume":"271","author":"Rose","year":"2018","journal-title":"J Contr Release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.tube.2023.102307_bib201","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/IAI.00786-13","article-title":"Mucosal vaccination against tuberculosis using inert bioparticles","volume":"81","author":"Reljic","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2023.102307_bib202","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/eji.201343887","article-title":"Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice","volume":"44","author":"Stylianou","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib203","first-page":"223","article-title":"Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant\/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen","volume":"3","author":"Karimi","year":"2016","journal-title":"Nanomed J"},{"key":"10.1016\/j.tube.2023.102307_bib204","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/j.vaccine.2012.03.016","article-title":"Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine","volume":"30","author":"Song","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib205","series-title":"The use of bacterial spore formers as probiotics","first-page":"813","author":"Hong","year":"2005"},{"key":"10.1016\/j.tube.2023.102307_bib206","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1016\/j.vaccine.2018.07.040","article-title":"Polysaccharides as vaccine adjuvants","volume":"36","author":"Sun","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib207","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejps.2014.05.028","article-title":"Development of novel carrier(s) mediated tuberculosis vaccine: more than a tour de force","volume":"62","author":"Garg","year":"2014","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.tube.2023.102307_bib208","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13238-015-0164-2","article-title":"Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies","volume":"6","author":"Wang","year":"2015","journal-title":"Protein & Cell"},{"key":"10.1016\/j.tube.2023.102307_bib209","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.micpath.2018.05.035","article-title":"Are chitosan natural polymers suitable as adjuvant\/delivery system for anti-tuberculosis vaccines?","volume":"121","author":"Khademi","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tube.2023.102307_bib210","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.1200492","article-title":"Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation","volume":"190","author":"Vaine","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib211","article-title":"Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants","author":"Silke","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.tube.2023.102307_bib212","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009980","article-title":"Rational design of small molecules as vaccine adjuvants","volume":"6","author":"Wu","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2023.102307_bib213","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1021\/mp400092y","article-title":"Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunization","volume":"10","author":"Primard","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.tube.2023.102307_bib214","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/1567201813666160721141322","article-title":"Highly immunogenic trimethyl chitosan-based delivery system for intranasal lipopeptide vaccines against group A Streptococcus","volume":"14","author":"Marasini","year":"2017","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.tube.2023.102307_bib215","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.1021\/jo020341q","article-title":"Chemical syntheses of inulin and levan structures","volume":"67","author":"Oscarson","year":"2002","journal-title":"J Org Chem"},{"key":"10.1016\/j.tube.2023.102307_bib216","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.11.015","article-title":"Advax, a delta inulin microparticle, potentiates in-built adjuvant property of Co-administered vaccines","volume":"15","author":"Hayashi","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tube.2023.102307_bib217","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1038\/s41598-017-09119-y","article-title":"Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection","volume":"7","author":"Counoupas","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2023.102307_bib218","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"Advax\u2122, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib219","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2014.10.008","article-title":"Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant","volume":"66","author":"Murugappan","year":"2015","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.tube.2023.102307_bib220","first-page":"935","volume":"61","author":"Baz Morelli","year":"2012","journal-title":"ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases"},{"key":"10.1016\/j.tube.2023.102307_bib221","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.01290-06","article-title":"The combined CTA1-DD\/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to","volume":"75","author":"Andersen","year":"2007","journal-title":"Mycobacterium tuberculosis. Infection and Immunity"},{"key":"10.1016\/j.tube.2023.102307_bib222","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.158.8.3936","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"Agren","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib223","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib224","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.it.2018.01.006","article-title":"New tuberculosis vaccine strategies: taking aim at un-natural immunity","volume":"39","author":"Jeyanathan","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib225","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/16000617.00002515","article-title":"Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisationdetermined T-cell homing to restricted lung mucosal compartments","volume":"24","author":"Lai","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.tube.2023.102307_bib226","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/eji.201040455","article-title":"Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection","volume":"40","author":"Caccamo","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib227","article-title":"Multifunctional CD4 T cell responses in patients with active","volume":"2","author":"Zhengang","year":"2012","journal-title":"Tubercul Sci Rep"},{"key":"10.1016\/j.tube.2023.102307_bib228","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007643","article-title":"A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates","volume":"15","author":"Rodo","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2023.102307_bib229","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/CVI.00721-14","article-title":"Quest for correlates of protection against tuberculosis","volume":"22","author":"Bhatt","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01973","article-title":"High antigen dose is detrimental to post-exposure vaccine protection against tuberculosis.(brief article)","volume":"8","author":"Billeskov","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib231","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2005.03.040","article-title":"Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis","volume":"23","author":"Sable","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2023.102307_bib232","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.4049\/jimmunol.166.3.1951","article-title":"A model to predict cell-mediated immune regulatory mechanisms during human infection with <em>Mycobacterium tuberculosis<\/em&gt","volume":"166","author":"Wigginton","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib233","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1574-695X.2006.00087.x","article-title":"Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration","volume":"47","author":"Giri","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.tube.2023.102307_bib234","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31\u00ae against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"Aagaard","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib235","first-page":"102","article-title":"L","volume":"145","author":"Henriksen-Lacey","year":"2010","journal-title":"iposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response"},{"key":"10.1016\/j.tube.2023.102307_bib236","first-page":"180","volume":"142","author":"Henriksen-Lacey","year":"2010","journal-title":"Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen"},{"key":"10.1016\/j.tube.2023.102307_bib237","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2567.2007.02560.x","article-title":"The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes","volume":"121","author":"Smith Korsholm","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2023.102307_bib238","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005771","article-title":"A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells","volume":"4","author":"Kamath","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2023.102307_bib239","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jconrel.2012.03.016","article-title":"A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog","volume":"160","author":"Christensen","year":"2012","journal-title":"J Contr Release"},{"key":"10.1016\/j.tube.2023.102307_bib240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1586\/14760584.2014.883285","article-title":"Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature","volume":"13","author":"Herzog","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2023.102307_bib241","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coi.2014.06.003","article-title":"Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis","volume":"29","author":"Sakai","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib242","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","article-title":"Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells","volume":"192","author":"Sakai","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2023.102307_bib243","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1080\/21645515.2016.1181236","article-title":"Mucosal adjuvants: opportunities and challenges","volume":"12","author":"Zeng","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tube.2023.102307_bib244","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051073","article-title":"Different methods and formulations of drugs and vaccines for nasal administration","volume":"14","author":"Tai","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tube.2023.102307_bib245","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/17425247.2011.565326","article-title":"Opportunities and challenges of the pulmonary route for vaccination","volume":"8","author":"Blank","year":"2011","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.tube.2023.102307_bib246","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/14760584.2019.1692657","article-title":"Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges","volume":"18","author":"Stylianou","year":"2019","journal-title":"Expert Rev Vaccines"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979223000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979223000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:11:20Z","timestamp":1778623880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979223000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":246,"alternative-id":["S1472979223000057"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2023.102307","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2023.102307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102307"}}